Plasma and Urinary Concentrations of Synephrine in Horses Following Controlled Oral Administration.

Overview

• This study investigated how synephrine, a regulatory-relevant compound, is absorbed, metabolized, and excreted in horses after oral doses.
• Researchers measured synephrine levels in horse blood plasma and urine to understand its concentration patterns and implications for equine sports regulation.

Introduction and Background

• Synephrine is a naturally occurring alkaloid with sympathomimetic effects, meaning it can stimulate the nervous system.
• It is of regulatory interest in horse racing and equestrian sports because synephrine can be detected in blood or urine due to feed contamination or supplements.
• Understanding synephrine’s pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes it) is important for interpreting test results and enforcing regulations.

Study Design and Methods

• Six Thoroughbred horses were selected for the study to ensure consistency in breed and size.
• Two different oral doses of synephrine were administered to the horses: 100 mg (low dose) and 800 mg (high dose).
• Blood plasma and urine samples were collected from the horses sequentially after administration to track concentration changes over time.
• Samples underwent analysis both before and after treatment with β-glucuronidase hydrolysis:
• β-glucuronidase hydrolysis breaks down conjugated metabolites to release free synephrine, allowing measurement of both free and conjugated forms.
• Analyzing samples before and after hydrolysis helps determine how much synephrine exists in bound versus free forms.
• Non-compartmental pharmacokinetic analysis was used to estimate key parameters such as:
• Half-life (time taken for synephrine concentration to reduce by half)
• Cmax (maximum concentration observed)
• Tmax (time to reach maximum concentration)
• AUC (Area Under the Concentration-time Curve, indicating total drug exposure)

Key Findings

• Synephrine was mostly present in plasma and urine as conjugated metabolites rather than in its free form, confirmed by increased measurements after β-glucuronidase hydrolysis.
• The hydrolysis step led to substantially higher detectable synephrine levels, indicating that direct measurements underestimate total exposure if conjugates are not considered.
• Synephrine was rapidly absorbed following oral administration, as shown by pharmacokinetic parameters.
• There was a clear dose-dependent increase in systemic circulation and urinary excretion, meaning higher doses lead to proportionally higher blood and urine concentrations.
• Pharmacokinetic results such as half-life and Tmax provide baseline data on how quickly synephrine appears and disappears in the horse’s body.

Implications and Applications

• This study provides the first quantitative profile of synephrine concentrations in horse plasma and urine post oral intake under controlled conditions.
• Understanding conjugated metabolite predominance informs regulatory testing protocols to include hydrolysis steps for accurate synephrine detection.
• The concentration ranges reported can help differentiate between synephrine exposure from feed sources and intentional administration.
• Regulatory bodies and veterinarians can better interpret field detections of synephrine with this pharmacokinetic information.
• The study supports future research on feed-related synephrine exposure and its metabolism in equine athletes, improving fairness and safety in equestrian sports.